Home LiteratureArticle Details
PMID: 10974039 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

The Journal of experimental medicine ·Vol. 192 ·No. 5 ·2000-09-04 ·Pages 741-54

Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M

Abstract

A major group of natural killer (NK) T cells express an invariant Valpha14(+) T cell receptor (TCR) specific for the lipoglycan alpha-galactosylceramide (alpha-GalCer), which is presented by CD1d. These cells may have an important immune regulatory function, but an understanding of their biology has been hampered by the lack of suitable reagents for tracking them in vivo. Here we show that tetramers of mouse CD1d loaded with alpha-GalCer are a sensitive and highly specific reagent for identifying Valpha14(+) NK T cells. Using these tetramers, we find that alpha-GalCer-specific T lymphocytes are more widely distributed than was previously appreciated, with populations of largely NK1.1(-) but tetramer-binding T cells present in the lymph nodes and the intestine. Injection of alpha-GalCer leads to the production of both interferon gamma and interleukin 4 by nearly all NK T cells in the liver and the majority of the spleen within 2 h. These cells mostly disappear by 5 h, and they do not reappear after 1 wk. Curiously, tetramer-positive thymocytes do not rapidly synthesize cytokines, nor do they undergo decreases in cell number after lipid antigen stimulation, although they express equivalent TCR levels. In summary, the data presented here demonstrate that alpha-GalCer-specific NK T cells undergo a unique and highly compartmentalized response to antigenic stimulation.

MeSH Terms
Animals Antigens/analysis Antigens, CD1/chemistry,physiology Antigens, CD1d Antigens, Ly Antigens, Surface Dimerization Galactosylceramides/immunology Immunophenotyping Killer Cells, Natural/immunology Lectins, C-Type Lymphocyte Activation Mice Mice, Inbred BALB C Mice, Inbred C57BL NK Cell Lectin-Like Receptor Subfamily B Proteins/analysis Receptors, Antigen, T-Cell, alpha-beta/analysis,physiology
Chemicals
Antigens Antigens, CD1 Antigens, CD1d Antigens, Ly Antigens, Surface Galactosylceramides Klrb1c protein, mouse Lectins, C-Type NK Cell Lectin-Like Receptor Subfamily B Proteins Receptors, Antigen, T-Cell, alpha-beta
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Matsuda J L
La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.
Naidenko O V
Gapin L
Nakayama T
Taniguchi M
Wang C R
Koezuka Y
Kronenberg M
References (57)
57 references, click to expand
  1. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Nature. 1998 Feb 19;391(6669):795-9 PMID: 9486650
  2. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.
    J Exp Med. 1999 Oct 4;190(7):963-72 PMID: 10510086
  3. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
    Cancer Res. 1998 Mar 15;58(6):1202-7 PMID: 9515806
  4. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    J Exp Med. 1998 Apr 6;187(7):1047-56 PMID: 9529321
  5. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.
    J Exp Med. 1999 Oct 18;190(8):1069-80 PMID: 10523605
  6. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    J Immunol. 1999 Nov 1;163(9):4647-50 PMID: 10528160
  7. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets.
    J Immunol. 1998 Apr 15;160(8):3681-8 PMID: 9558068
  8. A new look at T cells.
    J Exp Med. 1998 May 4;187(9):1367-71 PMID: 9565629
  9. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.
    Proc Natl Acad Sci U S A. 1998 May 12;95(10):5690-3 PMID: 9576945
  10. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.
    Immunity. 1998 Jun;8(6):675-82 PMID: 9655481
  11. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    J Immunol. 1998 Oct 1;161(7):3271-81 PMID: 9759842
  12. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis.
    Immunity. 1998 Sep;9(3):345-53 PMID: 9768754
  13. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
    J Exp Med. 1998 Oct 19;188(8):1521-8 PMID: 9782129
  14. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.
    J Exp Med. 1998 Oct 19;188(8):1529-34 PMID: 9782130
  15. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].
    Immunity. 1998 Oct;9(4):459-66 PMID: 9806632
  16. A population of CD62Llow Nk1.1- CD4+ T cells that resembles NK1.1+ CD4+ T cells.
    Eur J Immunol. 1998 Oct;28(10):3172-82 PMID: 9808186
  17. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    J Exp Med. 1998 Nov 16;188(10):1841-8 PMID: 9815261
  18. The Qa-1b molecule binds to a large subpopulation of murine NK cells.
    Eur J Immunol. 1998 Dec;28(12):4356-61 PMID: 9862372
  19. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR.
    Eur J Immunol. 1998 Dec;28(12):4391-7 PMID: 9862376
  20. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells.
    Science. 1999 Jan 8;283(5399):225-9 PMID: 9880256
  21. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis.
    J Exp Med. 1999 Feb 1;189(3):483-91 PMID: 9927510
  22. Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin.
    Eur J Immunol. 1999 Feb;29(2):650-9 PMID: 10064082
  23. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.
    Science. 1998 Mar 6;279(5356):1541-4 PMID: 9488653
  24. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
    J Immunol. 1999 Nov 15;163(10):5338-45 PMID: 10553057
  25. NKT cells are phenotypically and functionally diverse.
    Eur J Immunol. 1999 Nov;29(11):3768-81 PMID: 10556834
  26. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors.
    Eur J Immunol. 2000 Jan;30(1):236-44 PMID: 10602046
  27. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers.
    Eur J Immunol. 2000 Jan;30(1):300-7 PMID: 10602053
  28. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
    J Immunol. 2000 Feb 15;164(4):2009-15 PMID: 10657652
  29. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Cell Immunol. 2000 Jan 10;199(1):37-42 PMID: 10675273
  30. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.
    J Immunol. 2000 Mar 1;164(5):2412-8 PMID: 10679077
  31. Murine CD1d-restricted T cell recognition of cellular lipids.
    Immunity. 2000 Feb;12(2):211-21 PMID: 10714687
  32. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.
    Immunity. 2000 Mar;12(3):241-50 PMID: 10755611
  33. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
    Eur J Immunol. 2000 Apr;30(4):985-92 PMID: 10760785
  34. Production of soluble MHC class II proteins with covalently bound single peptides.
    Nature. 1994 May 12;369(6476):151-4 PMID: 8177320
  35. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice.
    J Med Chem. 1995 Jun 9;38(12):2176-87 PMID: 7783149
  36. Peptide binding and presentation by mouse CD1.
    Science. 1995 Jul 14;269(5221):223-6 PMID: 7542403
  37. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.
    J Exp Med. 1995 Oct 1;182(4):993-1004 PMID: 7561702
  38. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.
    J Exp Med. 1995 Oct 1;182(4):1163-8 PMID: 7561690
  39. Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice.
    Biol Pharm Bull. 1996 Mar;19(3):350-3 PMID: 8924898
  40. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    J Exp Med. 1996 Jul 1;184(1):131-9 PMID: 8691126
  41. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  42. KRN7000, a novel immunomodulator, and its antitumor activities.
    Oncol Res. 1995;7(10-11):529-34 PMID: 8866665
  43. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells.
    J Exp Med. 1996 Oct 1;184(4):1285-93 PMID: 8879200
  44. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse.
    Eur J Immunol. 1996 Dec;26(12):2989-98 PMID: 8977295
  45. Mouse CD1-specific NK1 T cells: development, specificity, and function.
    Annu Rev Immunol. 1997;15:535-62 PMID: 9143699
  46. IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.
    J Immunol. 1997 Jul 1;159(1):7-10 PMID: 9200431
  47. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
    Science. 1997 Nov 28;278(5343):1623-6 PMID: 9374462
  48. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Science. 1997 Nov 28;278(5343):1626-9 PMID: 9374463
  49. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.
    Nature. 1998 Jan 8;391(6663):177-81 PMID: 9428763
  50. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    J Exp Med. 1999 Apr 5;189(7):1073-81 PMID: 10190898
  51. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    J Exp Med. 1999 Apr 5;189(7):1121-8 PMID: 10190903
  52. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
    J Exp Med. 1999 Apr 5;189(7):1149-56 PMID: 10190906
  53. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    J Immunol. 1999 Jun 1;162(11):6410-9 PMID: 10352254
  54. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
    Eur J Immunol. 1999 Jun;29(6):2014-25 PMID: 10382765
  55. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.
    Immunity. 1999 Jul;11(1):67-77 PMID: 10435580
  56. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    J Immunol. 1999 Sep 1;163(5):2373-7 PMID: 10452969
  57. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
    J Exp Med. 1999 Sep 20;190(6):783-92 PMID: 10499917
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2000-09-04
Pages
741-54
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193268
Subset
IM
Grants
NIAID NIH HHS · R01 AI043407 · United States
NIAID NIH HHS · R01 AI043407-04 · United States
NCI NIH HHS · R01 CA52511 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com